Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gastroenterology
»
Gastrointestinal
»
Inflammatory Bowel Disease
28. October 2025
Search
medline.ch
Inflammatory Bowel Disease
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Diarrhea
Inflammatory Bowel Disease
Functional Diseases
Gastroenteritis
Gastrointestinal Hemorrhage
Neoplasms
Peptic Ulcer
Others
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 2761
Articles 1 - 20 / 55206
Bowel Urgency Severity Among Patients with Crohn's Disease or Ulcerative Colitis on Advanced Therapies: Real-World Data Using Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease.
Gastro Hep Adv
Lewis JD, Maria Chan WM, Moses RE, Zhou X, Wang Y, Jha P, Gibble TH.
PMID: 41142524 [PubMed]
A Retrospective Cohort Propensity-Matched Analysis of Colorectal Cancer Risk in Isolated Small Intestinal Crohn's Disease.
Gastro Hep Adv
Alsakarneh S, Al Ta'ani O, Quezada S, Raufman JP, Shaukat A, Ghoz H.
PMID: 41142519 [PubMed]
Targeting the PI3K/Akt pathway for the treatment of ulcerative colitis: integrative regulatory features of traditional Chinese medicine.
Front Pharmacol
Niu S, Zhang Y.
PMID: 41142246 [PubMed]
Comparative Efficacy of all Available Pharmaceutical Therapies for Moderate to Severe Crohn's Disease: A Systematic Review and Network Meta-Analysis.
Gastro Hep Adv
Versteegh M, Idema DL, Huygens S, Jenniskens K, Pierik M, Römkens T, van Schaik F, Wahab P, Huis In't Veld LF, Kusters M, van der Braak K, Hooft L, Damen JAA.
PMID: 41140764 [PubMed]
Research trends of intestinal barrier in ulcerative colitis: a bibliometric analysis.
Front Med (Lausanne)
Chen Q, Chen Q.
PMID: 41140699 [PubMed]
Long-term safety of ustekinumab in Crohn's disease: Descriptive analysis from an observational post-authorisation safety study using I-CARE cohort data.
Dig Liver Dis
Peyrin-Biroulet L, Nazar M, Sheahan A, Geldhof A, Azzabi A, Baert F, Mailhat C, Rousseau H, Rahier JF, Beaugerie L.
PMID: 41139534 [PubMed - as supplied by publisher]
Novel endoluminal parameters for predicting primary loss of response in Crohn's disease: a multi-center study.
Insights Imaging
Yao R, Cai C, Liang J, Tian F, Cao X, Li Y, Gu Y, Feng Q, Shen J, Mimic Inflammatory Bowel Disease Research Group.
PMID: 41139179 [PubMed]
Therapeutic management and risk of colectomy in patients with acute severe ulcerative colitis and previous exposure to anti-TNF drugs: a comparative study of GETECCU.
J Crohns Colitis
Francisco M, Alicia LG, José MB, Cristina RC, Ignacio MJ, Cristina SF, Albert MC, Esteban FV, Alejando M, Andrés C, Cristina R, Agnès FC, Jerusalén GC, Begoña ÁH, José GM, José Xavier SO, María Carmen RG, Romero-Salazar Francisco L, Ignacio O, Daniel MR, María GV, Ángel PD, Iria BR, María BJ, Cristina R, González Ernesto Alejandro L, Genaro DP, Leyanira T, Alejandro HC, Lorena B, Gisela P, Eduard B, Martín I, Miquel MC, Yamile Z, Ana G, of GETECCU.
PMID: 41137689 [PubMed - as supplied by publisher]
Sequencing Therapy for Optimal Response in Mirikizumab (STORM)-study: A tertiary referral center study on patients with therapy-refractory ulcerative colitis.
PLoS One
Kubesch A, Lande R, Leutgöb A, Farrag K, Dahmer I, Stratmann-Vollrath K, Dienethal A, Michael FA, Sprinzl K, Zeuzem S, Blumenstein I.
PMID: 41134755 [PubMed - indexed for MEDLINE]
Baseline Fusobacterium Abundance Predicts Ustekinumab Response in Crohn's Disease: A Prospective Microbiome Cohort Study.
Microb Biotechnol
Wang C, Hao Y, Liu Y, He L, Xu S, Zhang M, Wang X, Wang H.
PMID: 41134684 [PubMed - indexed for MEDLINE]
The impact of E-Cigarettes and Heat-Not-Burn Tobacco on Postoperative Recurrence of Crohn's Disease: A Multicenter International Study.
Am J Gastroenterol
Parigi TL, Nardone OM, Lisa M, Massimino L, Gabbiadini R, Innocenti T, Bertani L, Del Gaudio A, Florez P, Bertin L, Barberio B, Hupé M, Lopetuso L, Allocca M, D'Amico F, Furfaro F, Zilli A, Fiorino G, Ungaro F, Castiglione F, Savarino E, Dragoni G, Scaldaferri F, Armuzzi A, Peyrin-Biroulet L, Jairath V, Pizarro TT, Danese S.
PMID: 41134080 [PubMed - as supplied by publisher]
The Effects of the Crohn's Disease Exclusion Diet (CDED) Alone Versus CDED Plus Partial Enteral Nutrition (PEN) on Gut Microbiome Composition in Pediatric CD Patients.
Microbiologyopen
Rohani P, Ansari A, Shaygantabar M, Hekmatdoost A, Sohouli MH.
PMID: 41133990 [PubMed - indexed for MEDLINE]
Prospects of AI-Powered Bowel Sound Analytics for Diagnosis, Characterization, and Treatment Management of Inflammatory Bowel Disease.
Med Sci (Basel)
Sood D, Riaz ZM, Mikkilineni J, Ravi NN, Chidipothu V, Yerrapragada G, Elangovan P, Shariff MN, Natarajan T, Janarthanan J, Asadimanesh N, Karuppiah SS, Gopalakrishnan K, Arunachalam SP.
PMID: 41133513 [PubMed - indexed for MEDLINE]
Dysregulated programmed cell death of intestinal epithelial cells in ulcerative colitis: Molecular mechanisms and novel therapeutic interventions (Review).
Int J Mol Med
Wu B, Su S, Li Y, Guo L.
PMID: 41133477 [PubMed - indexed for MEDLINE]
A Comprehensive Review of the Role of Biologics and Small-Molecule Therapies in the Long-Term Management of Crohn's Disease.
Cureus
Zaidi SF, Patel KB, Cerdas MG, Timalsina E, Rajendiran A, Behbehani D, Aljallawi SM, Pendurthi G, Ullah S, Bellaha MN, Gebregiorgis T, Nazir Z.
PMID: 41133018 [PubMed]
Th17/Treg imbalance in inflammatory bowel disease: immunological mechanisms and microbiota-driven regulation.
Front Immunol
Hu Y, Yang Y, Li Y, Zhang Q, Zhang W, Jia J, Han Z, Wang J.
PMID: 41132656 [PubMed - indexed for MEDLINE]
Diffuse Large B-cell Lymphoma Developing on the Background of Long-standing Ulcerative Colitis: A Case Report.
Korean J Gastroenterol
Phan NT, Ho PT, Ma NP, Nguyen CH, Huynh TDN, Hoang TV, Pham TQ.
PMID: 41132025 [PubMed - indexed for MEDLINE]
Repurposing minocycline as an added-on treatment for ulcerative colitis patients on mesalamine: a randomized clinical pilot study.
Naunyn Schmiedebergs Arch Pharmacol
Mashaly AF, Hegazy SK, Bahgat MM.
PMID: 41128897 [PubMed - as supplied by publisher]
Identification of biomarkers for treatment escalation of ulcerative colitis based on untargeted metabolomics and machine learning algorithms: A prospective cohort study.
Clin Transl Gastroenterol
Han M, Wang H, Zhu S, Li P, Shi H, Wu Y.
PMID: 41128818 [PubMed - as supplied by publisher]
One-liter polyethylene glycol with ascorbic acid provides comparable cleansing quality to two-liter regimen in bowel preparation for patients with inactive ulcerative colitis ‒ A randomized, multicenter, single-blind trial.
Rev Esp Enferm Dig
Lee JM, Lee KM, Shin SJ, Kim DH.
PMID: 41128099 [PubMed - as supplied by publisher]
Articles 1 - 20 / 55206
Page 1 of 2761
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy